| Functional exhaustion of CD4+ T cells induced by co‐stimulatory signals from myeloid leukaemia cells D Ozkazanc, D Yoyen‐Ermis, E Tavukcuoglu, Y Buyukasik, G Esendagli Immunology 149 (4), 460-471, 2016 | 67 | 2016 |
| Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer H Tonbul, A Sahin, E Tavukcuoglu, G Esendagli, Y Capan Journal of Drug Delivery Science and Technology 54, 101380, 2019 | 38 | 2019 |
| Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS D Yoyen-Ermis, G Tunali, E Tavukcuoglu, U Horzum, D Ozkazanc, T Sutlu, ... Scientific reports 9 (1), 11697, 2019 | 38 | 2019 |
| Functional responsiveness of memory T cells from COVID-19 patients E Tavukcuoglu, U Horzum, AC Inkaya, S Unal, G Esendagli Cellular Immunology 365, 104363, 2021 | 33 | 2021 |
| Aggregation of chitosan nanoparticles in cell culture: Reasons and resolutions K Ozturk, FB Arslan, E Tavukcuoglu, G Esendagli, S Calis International Journal of Pharmaceutics 578, 119119, 2020 | 32 | 2020 |
| Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer E Tavukcuoglu, U Horzum, H Yanik, A Uner, D Yoyen‐Ermis, SK Nural, ... European journal of immunology 50 (12), 2067-2074, 2020 | 28 | 2020 |
| Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells H Tonbul, A Sahin, E Tavukcuoglu, G Ultav, S Akbas, Y Aktas, ... Journal of Drug Delivery Science and Technology 63, 102535, 2021 | 23 | 2021 |
| Protocol to assess the suppression of T-cell proliferation by human MDSC AM Bruger, C Vanhaver, K Bruderek, G Amodio, E Tavukçuoğlu, ... Methods in enzymology 632, 155-192, 2020 | 21 | 2020 |
| Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer M Kwa, X Li, Y Novik, R Oratz, K Jhaveri, J Wu, P Gu, M Meyers, F Muggia, ... Breast Cancer Research and Treatment 168, 57-67, 2018 | 19 | 2018 |
| Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosan S Yüksel, M Pekcan, N Puralı, G Esendağlı, E Tavukçuoğlu, ... International Journal of Pharmaceutics 578, 119129, 2020 | 17 | 2020 |
| Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors S Anthiya, SC Öztürk, H Yanik, E Tavukcuoglu, A Şahin, D Datta, ... Journal of Controlled Release 357, 67-83, 2023 | 16 | 2023 |
| Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes MA Kursunel, EZ Taskiran, E Tavukcuoglu, H Yanik, F Demirag, ... Cancer Immunology, Immunotherapy, 1-15, 2022 | 14 | 2022 |
| Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier I Seko, H Tonbul, E Tavukçuoğlu, A Şahin, S Akbas, H Yanık, SC Öztürk, ... Journal of Drug Delivery Science and Technology 66, 102867, 2021 | 13 | 2021 |
| A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet’s Disease EZ Taskiran, HE Sonmez, C Kosukcu, E Tavukcuoglu, G Yazici, ... Journal of Clinical Immunology 39, 99-105, 2019 | 11 | 2019 |
| PD‐L2+ wound zone macrophage‐like cells display M1/M2‐mixed activation and restrain the effector Th1 responses E Tavukcuoglu, U Horzum, KB Yilmaz, G Esendagli Immunology and Cell Biology 98 (2), 152-164, 2020 | 9 | 2020 |
| Effects of particle geometry for PLGA-based nanoparticles: Preparation and in vitro/in vivo evaluation M Kaplan, K Öztürk, SC Öztürk, E Tavukçuoğlu, G Esendağlı, S Calis Pharmaceutics 15 (1), 175, 2023 | 8 | 2023 |
| A novel combination for the treatment of small cell lung cancer: Active targeted irinotecan and stattic co-loaded PLGA nanoparticles FB Arslan, K Öztürk, E Tavukçuoğlu, SC Öztürk, G Esendağlı, S Çalış International Journal of Pharmaceutics 632, 122573, 2023 | 5 | 2023 |
| pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML) G Ultav, H Tonbul, E Tavukcuoglu, SC Ozturk, S Akbas, A Sahin, ... Journal of Nanoparticle Research 24 (2), 40, 2022 | 5 | 2022 |
| Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination M Hafızoğlu, AO Bas, E Tavukçuoğlu, Z Sahiner, MG Oytun, S Ulutürk, ... Clinical Immunology Communications 2, 154-158, 2022 | 1 | 2022 |
| Immune checkpoint status and exhaustion‐related phenotypes of CD8+ T cells from the tumor‐draining regional lymph nodes in breast cancer I Yilmaz, E Tavukcuoglu, U Horzum, KB Yilmaz, M Akinci, MA Gulcelik, ... Cancer Medicine 12 (24), 22196-22205, 2023 | | 2023 |
